Gene inactivated mutants with altered protein production

US9273279B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9273279-B2
Application numberUS-201414217904-A
CountryUS
Kind codeB2
Filing dateMar 18, 2014
Priority dateApr 12, 2005
Publication dateMar 1, 2016
Grant dateMar 1, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A recombinant filamentous fungal cell (e.g. Aspergillus ) having one or more inactivated chromosomal genes is provided. The chromosomal genes in some embodiments correspond to derA, derB, htmA, mnn9, mnn10, ochA, dpp4, dpp5, pepAa, pepAb, pepAc, pepAd, pepF and combinations thereof. The recombinant fungal cells may include further inactivated chromosomal genes which correspond to pepA, pepB, pepC and pepD. The recombinant filamentous fungal cells may include a heterologous nucleic acid encoding a protein of interest. Also provided are methods of producing a protein of interest in said recombinant filamentous fungal cell.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a protein of interest in a filamentous fungal cell comprising a) obtaining a recombinant filamentous fungal cell comprising one or more inactivated chromosomal genes selected from derB (SEQ ID NO:3), mnn9 (SEQ ID NO:7), mnn10 (SEQ ID NO:9), ochA (SEQ ID NO:11), dpp4 (SEQ ID NO:13), pepAa (SEQ ID NO:17), pepAb (SEQ ID NO:19), pepAc (SEQ ID NO:31), pepAd (SEQ ID NO:21), pepF (SEQ ID NO:23), functionally homologous sequences thereto, wherein the functionally homologous sequences have at least 95% sequence identity thereto, and combinations thereof, b) introducing a nucleic acid sequence which encodes a protein of interest into said recombinant fungal cell, and c) growing the recombinant fungal cell under suitable culture conditions for the expression and production of said protein of interest. 2. The method according to claim 1 further comprising recovering the protein of interest. 3. The method according to claim 2 , wherein the expression of the protein of interest is enhanced compared to the expression of said protein of interest in a corresponding parent cell. 4. The method according to claim 3 , wherein the filamentous fungal cell is Aspergillus cell. 5. A method for obtaining a protein of interest from an Aspergillus strain comprising a) obtaining a recombinant Aspergillus cell comprising one or more inactivated chromosomal genes selected from derB (SEQ ID NO:3), mnn9 (SEQ ID NO:7), mnn10 (SEQ ID NO:9), ochA (SEQ ID NO:11), dpp4 (SEQ ID NO:13), pepAa (SEQ ID NO:17), pepAb (SEQ ID NO:19), pepAc (SEQ ID NO:31), pepAd (SEQ ID NO:21), pepF (SEQ ID NO:23), functionally homologous sequences thereto, wherein the functionally homologous sequences have at least 95% sequence identity thereto, and combinations thereof; b) transforming the recombinant Aspergillus cell with a nucleic acid sequence encoding a protein of interest; c) growing the transformed Aspergillus cell under suitable growth conditions to allow expression of the protein of interest, and d) recovering said protein. 6. The method according to claim 5 , wherein the protein is a protease inhibitor. 7. The method according to claim 5 , wherein the protein is an antibody or fragment thereof. 8. The method according to claim 5 , wherein the protein is an enzyme. 9. The method according to claim 5 , wherein the Aspergillus is A. niger. 10. The method according to claim 1 , wherein the recombinant filamentous fungal cell comprises two inactivated chromosomal genes. 11. The method according to claim 10 , wherein the two inactivated chromosomal genes are mnn9 (SEQ ID NO:7) and ochA (SEQ ID NO:11), or homologous sequences thereto having at least 95% sequence identity thereto. 12. The method according to claim 1 , wherein the inactivated gene has been deleted. 13. The method according to claim 1 , wherein the inactivated gene has been disrupted.

Assignees

Inventors

Classifications

  • C12N9/0061Primary

    Laccase (1.10.3.2) · CPC title

  • Lyases (4.) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Laccase (1.10.3.2) · CPC title

  • C12N1/14Primary

    Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9273279B2 cover?
A recombinant filamentous fungal cell (e.g. Aspergillus ) having one or more inactivated chromosomal genes is provided. The chromosomal genes in some embodiments correspond to derA, derB, htmA, mnn9, mnn10, ochA, dpp4, dpp5, pepAa, pepAb, pepAc, pepAd, pepF and combinations thereof. The recombinant fungal cells may include further inactivated chromosomal genes which correspond to pepA, pepB, p…
Who is the assignee on this patent?
Danisco Us Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/0061. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).